Clinical Trials

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT02676349 2026-03-27

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Phase 2 Completed

130 enrolled

Pancreatic Neoplasms

NCT04503694 2026-03-27

REGINA

72 enrolled

Rectal Neoplasms

NCT06850103 2026-03-25

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

51 enrolled

Colorectal Neoplasms

NCT06258525 2026-03-18

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

NCT06269978 2026-03-10

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Phase 1 Recruiting

24 enrolled

Colorectal Neoplasms

NCT04215731 2026-03-03

FOBEAR

Phase 3 Recruiting

582 enrolled

Rectal Neoplasms

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Advanced Biliary Tract Carcinoma

NCT06307548 2026-02-10

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Phase 1/2 Suspended

21 enrolled

Colorectal Neoplasms

NCT07162506 2026-02-04

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Esophageal Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

Phase 3 Recruiting

2,000 enrolled

Esophageal Neoplasms

NCT06468280 2026-01-21

ROSETTE

84 enrolled

Stomach Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Phase 2 Enrolling by invitation

Esophageal Squamous Cell Carcinoma

NCT07139951 2025-12-31

HORIZON

16 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT03042169 2025-12-23

SURGIGAST

Phase 3 Terminated

6 enrolled

Stomach Neoplasms

NCT04587739 2025-12-23

KARCHER-1

Phase 1 Recruiting

Carcinoma, Hepatocellular

NCT06576921 2025-12-23

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

116 enrolled

Stomach Neoplasms

NCT07290764 2025-12-18

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

Enrolling by invitation

729 enrolled

Phase NA Active not recruiting

Carcinoma, Hepatocellular

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

2 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Phase 1 Terminated

4 enrolled

Pancreatic Neoplasms

NCT06994299 2025-11-18

PRISM

Phase 2 Withdrawn

Carcinoma, Hepatocellular

NCT04982653 2025-11-10

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

140 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

168 enrolled

Pancreatic Neoplasms

NCT07200141 2025-09-30

SIB-NCRT-pumch

156 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT04809025 2025-09-29

EBPS

510 enrolled

Stomach Neoplasms

NCT07194616 2025-09-26

Rectal Cancer CTC Trial

Phase NA Recruiting

120 enrolled

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT07183280 2025-09-19

SPN

2,000 enrolled

Solid Pseudopapillary Neoplasm of the Pancreas

NCT07162714 2025-09-09

STAR

Rectal Neoplasms

NCT05760404 2025-09-08

CB1 - CONTRACT

Completed

36 enrolled

Colorectal Neoplasms

NCT06574373 2025-09-03

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

3,600 enrolled

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT05265208 2025-08-06

SIROCHO

62 enrolled

Resectable Intrahepatic Cholangiocarcinoma

NCT06476067 2025-07-11

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

150 enrolled

Esophageal Neoplasms, Recurrence

NCT04958720 2025-07-03

AGAMENON

10,000 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

50 enrolled

Esophageal Neoplasms, Esophagitis

NCT04404777 2025-06-17

LERIS

Active not recruiting

12,000 enrolled

Rectal Neoplasms

NCT06646445 2025-06-13

PREMICES

60 enrolled

Phase 2/3 Not yet recruiting

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT07000253 2025-06-02

OMEC-5

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06908031 2025-05-14

CRIT

49 enrolled

Phase NA Active not recruiting

Rectal Neoplasms

NCT01792934 2025-04-15

ORCHESTRA

478 enrolled

Multi-organ Metastatic Colorectal Cancer

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT06898398 2025-04-03

TACE Combined Surgery for the Resectable Huge HCC

326 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06293625 2025-03-30

FOxTROT2France

Phase 3 Recruiting

150 enrolled

Colonic Neoplasms

NCT06246344 2025-03-12

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

128 enrolled

Rectal Neoplasms

NCT02972372 2025-02-10

CELAEC

Phase NA Recruiting

196 enrolled

Esophageal Neoplasms

NCT05296005 2025-02-07

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Phase 1 Withdrawn

Clinical Stage I Gastric Cancer AJCC v8

NCT02000050 2025-01-30

COLORE

Phase 2 Completed

52 enrolled

Rectal Neoplasms

NCT06622720 2025-01-24

Laparoscopic Elective Colorectal Procedures Performed by Supervised Residents Are Safe and Sufficient.

Completed

498 enrolled